Archive | Publications

Governance of Research Melanoma

MRV is a multisite collaboration of clinical and non-clinical researchers, cohort participants and consumers.

Read the full story

Posted in Melanoma News, MRV Newsletters, Publications

Immune checkpoint inhibitors for cancer and venous thromboembolic events

BACKGROUND: Immune checkpoint inhibitors (ICIs) are widely used cancer treatments.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications

Declining cancer incidence in the elderly: decreasing diagnostic intensity or biology?

BACKGROUND: Advanced age is a consistent risk factor for cancer, nonetheless cancer incidence typically declines after age 75-85 for most solid tumors.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications

FDA Grants Fast Track Status to UVI Plus Checkpoint Inhibition for Melanoma Subgroup

The FDA has granted a fast track designation to UV1, a universal cancer vaccine, in combination with either pembrolizumab (Keytruda) or…

Read the full story

Posted in Melanoma News, Regulatory, Publications